Effect of downregulation of FBI-1 on proliferation of human breast carcinoma cell line and its mechanism
10.19401/j.cnki.1007-3639.2017.04.004
- VernacularTitle:干扰FBI-1表达对人乳腺癌细胞增殖的影响及其作用机制研究
- Author:
Li WANG
;
Qinghong QIN
;
Qixing TAN
;
Bin LIAN
;
Weiping YANG
;
Changyuan WEI
- Keywords:
Factor that binds to the inducer of short transcripts of human immunodeficiency virus-1;
Breast cancer;
Cell proliferation;
NF-κB
- From:
China Oncology
2017;27(4):262-267
- CountryChina
- Language:Chinese
-
Abstract:
Background and purpose: Factor that binds to the inducer of short transcripts of human immuno-deficiency virus-1 (FBI-1) in a variety of malignant tumors showed high expression levels, which may be closely related to tumor proliferation and differentiation, angiogenesis, metastasis, but its relationship with breast cancer has not been fully elucidated. The purpose of this study was to investigate the expression of FBI-1 in breast cancer cells, and to study the effect of FBI-1 gene expression on the proliferation of breast cancer cells and its possible mechanism. Methods:Real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) and Western blot analysis were applied to detect FBI-1 expression in normal human mammary epithelial cell line MCF-10A and breast cancer cell MCF-7. RNA interference method was used to down-regulate FBI-1 expression in MCF-7 cells. The cell proliferation was measured by CCK-8 kit and colony formation assay. RTFQ-PCR and Western blot were used to detect the expression of FBI-1 and NF-κBp65 in MCF-7 cells before and after the interference of FBI-1 expression. Results: The expression of FBI-1 was higher in breast cancer cells than that in normal human mammary epithelial cells (P<0.05). The effects of FBI-1 down-regulation inhibited proliferation in MCF-7 cells (P<0.05). At the same time, after inhibition of FBI-1, the NF-κBp65 mRNA and protein expression levels were significantly decreased (P<0.05). Conclusion: FBI-1 is highly expressed in breast cancer cells. Down-regulated FBI-1 expression can inhibit the proliferation of breast cancer cells,and its mechanism may be related to the inhibition of NF-κB signaling pathway.
